Canakinumab treatment real world evidence in 3 monogenic periodic fever syndromes in 2009 –2022: an interim analysis using the French JIR cohort database

Our study aimed to provide real-world evidence on the treatment patterns, effectiveness and safety of canakinumab in France in Familial Mediterranean Fever (FMF), Mevalonate Kinase Deficiency (MKD), and Tumor ...

Source: Arthritis Research and Therapy - April 8, 2024 Category: Rheumatology Authors: Isabelle Kon é-Paut, Sophie Georgin-Lavialle, Alexandre Belot, Magali Jover, Mathilde Pouriel, Laure Lacoin, Pascal Pillet and Véronique Hentgen Tags: Research Source Type: research